BMN 349

· BioMarin Pharmaceutical

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMN 349, covering 2025-09-08 to 2025-09-08. Get the full timeline:

Most recent: Clinical Trial Update: Study of BMN 349 Single Dose in PiZZ and PiMZ/MASH Adult Participants [Phase 1]